Treatment outcomes according to various progestin treatment strategies in patients with atypical hyperplasia/endometrial intraepithelial neoplasia - Multicenter retrospective study (KGOG2033)
CONCLUSIONS: Although OP alone achieved more short-term pCR than the other groups, more recurrences occurred after pCR than LNG-IUD alone. High-dose OP as well as combination of OP and LNG-IUD did not increase pCR or reduce recurrence. Maintenance therapy may reduce the recurrence rate after pCR.PMID:38520881 | DOI:10.1016/j.ygyno.2024.03.017 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - March 23, 2024 Category: Cancer & Oncology Authors: Nam Kyeong Kim Chel Hun Choi Seok Ju Seong Jong-Min Lee Banghyun Lee Kidong Kim Source Type: research
Sentinel lymph node biopsy in high-risk endometrial cancer: The d énouement
Gynecol Oncol. 2024 Mar;182:A1-A2. doi: 10.1016/j.ygyno.2024.03.012.NO ABSTRACTPMID:38521580 | DOI:10.1016/j.ygyno.2024.03.012 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - March 23, 2024 Category: Cancer & Oncology Authors: Gretchen E Glaser Sean C Dowdy Source Type: research
Treatment outcomes according to various progestin treatment strategies in patients with atypical hyperplasia/endometrial intraepithelial neoplasia - Multicenter retrospective study (KGOG2033)
CONCLUSIONS: Although OP alone achieved more short-term pCR than the other groups, more recurrences occurred after pCR than LNG-IUD alone. High-dose OP as well as combination of OP and LNG-IUD did not increase pCR or reduce recurrence. Maintenance therapy may reduce the recurrence rate after pCR.PMID:38520881 | DOI:10.1016/j.ygyno.2024.03.017 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - March 23, 2024 Category: Cancer & Oncology Authors: Nam Kyeong Kim Chel Hun Choi Seok Ju Seong Jong-Min Lee Banghyun Lee Kidong Kim Source Type: research
Sentinel lymph node biopsy in high-risk endometrial cancer: The d énouement
Gynecol Oncol. 2024 Mar;182:A1-A2. doi: 10.1016/j.ygyno.2024.03.012.NO ABSTRACTPMID:38521580 | DOI:10.1016/j.ygyno.2024.03.012 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - March 23, 2024 Category: Cancer & Oncology Authors: Gretchen E Glaser Sean C Dowdy Source Type: research
Treatment outcomes according to various progestin treatment strategies in patients with atypical hyperplasia/endometrial intraepithelial neoplasia - Multicenter retrospective study (KGOG2033)
CONCLUSIONS: Although OP alone achieved more short-term pCR than the other groups, more recurrences occurred after pCR than LNG-IUD alone. High-dose OP as well as combination of OP and LNG-IUD did not increase pCR or reduce recurrence. Maintenance therapy may reduce the recurrence rate after pCR.PMID:38520881 | DOI:10.1016/j.ygyno.2024.03.017 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - March 23, 2024 Category: Cancer & Oncology Authors: Nam Kyeong Kim Chel Hun Choi Seok Ju Seong Jong-Min Lee Banghyun Lee Kidong Kim Source Type: research
Sentinel lymph node biopsy in high-risk endometrial cancer: The d énouement
Gynecol Oncol. 2024 Mar;182:A1-A2. doi: 10.1016/j.ygyno.2024.03.012.NO ABSTRACTPMID:38521580 | DOI:10.1016/j.ygyno.2024.03.012 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - March 23, 2024 Category: Cancer & Oncology Authors: Gretchen E Glaser Sean C Dowdy Source Type: research
Treatment outcomes according to various progestin treatment strategies in patients with atypical hyperplasia/endometrial intraepithelial neoplasia - Multicenter retrospective study (KGOG2033)
CONCLUSIONS: Although OP alone achieved more short-term pCR than the other groups, more recurrences occurred after pCR than LNG-IUD alone. High-dose OP as well as combination of OP and LNG-IUD did not increase pCR or reduce recurrence. Maintenance therapy may reduce the recurrence rate after pCR.PMID:38520881 | DOI:10.1016/j.ygyno.2024.03.017 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - March 23, 2024 Category: Cancer & Oncology Authors: Nam Kyeong Kim Chel Hun Choi Seok Ju Seong Jong-Min Lee Banghyun Lee Kidong Kim Source Type: research
Sentinel lymph node biopsy in high-risk endometrial cancer: The d énouement
Gynecol Oncol. 2024 Mar;182:A1-A2. doi: 10.1016/j.ygyno.2024.03.012.NO ABSTRACTPMID:38521580 | DOI:10.1016/j.ygyno.2024.03.012 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - March 23, 2024 Category: Cancer & Oncology Authors: Gretchen E Glaser Sean C Dowdy Source Type: research
Treatment outcomes according to various progestin treatment strategies in patients with atypical hyperplasia/endometrial intraepithelial neoplasia - Multicenter retrospective study (KGOG2033)
CONCLUSIONS: Although OP alone achieved more short-term pCR than the other groups, more recurrences occurred after pCR than LNG-IUD alone. High-dose OP as well as combination of OP and LNG-IUD did not increase pCR or reduce recurrence. Maintenance therapy may reduce the recurrence rate after pCR.PMID:38520881 | DOI:10.1016/j.ygyno.2024.03.017 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - March 23, 2024 Category: Cancer & Oncology Authors: Nam Kyeong Kim Chel Hun Choi Seok Ju Seong Jong-Min Lee Banghyun Lee Kidong Kim Source Type: research
Sentinel lymph node biopsy in high-risk endometrial cancer: The d énouement
Gynecol Oncol. 2024 Mar;182:A1-A2. doi: 10.1016/j.ygyno.2024.03.012.NO ABSTRACTPMID:38521580 | DOI:10.1016/j.ygyno.2024.03.012 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - March 23, 2024 Category: Cancer & Oncology Authors: Gretchen E Glaser Sean C Dowdy Source Type: research
Dedicated financial hardship screening adds value to routine distress screening among gynecologic cancer patients
CONCLUSIONS: Dedicated FH screening was feasible and acceptable, but sensitivity was low. Importantly, 40% of women with FH would not have been identified with distress screening alone.PMID:38518528 | DOI:10.1016/j.ygyno.2024.03.014 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - March 22, 2024 Category: Cancer & Oncology Authors: Margaret I Liang Jhalak D Dholakia Grace M Lee Lingling Wang Tavonna D Kako Isabella Blair Courtney P Williams Rebecca C Arend Warner K Huh Gabrielle B Rocque Maria Pisu Source Type: research
Alpelisib for PIK3CA-mutated advanced gynecological cancers: First clues of clinical activity
CONCLUSION: Alpelisib represents an active treatment option in patients with recurrent gynecological cancers harboring a PIK3CA mutation. These findings support the need of biomarker-driven randomized trials of PI3K inhibitors in gynecological cancers.PMID:38518529 | DOI:10.1016/j.ygyno.2024.02.029 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - March 22, 2024 Category: Cancer & Oncology Authors: Anna Passarelli Vittoria Carbone Sandro Pignata Roberta Mazzeo Domenica Lorusso Giovanni Scambia Stefania Canova Teresa Di Palma Giulia Tasca Mara Mantiero Emanuele Naglieri Claudia Andreetta Martina Rauso Anna Elisabetta Brunetti Letizia Laera Chiara Abe Source Type: research
Alpelisib for PIK3CA-mutated advanced gynecological cancers: First clues of clinical activity
CONCLUSION: Alpelisib represents an active treatment option in patients with recurrent gynecological cancers harboring a PIK3CA mutation. These findings support the need of biomarker-driven randomized trials of PI3K inhibitors in gynecological cancers.PMID:38518529 | DOI:10.1016/j.ygyno.2024.02.029 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - March 22, 2024 Category: Cancer & Oncology Authors: Anna Passarelli Vittoria Carbone Sandro Pignata Roberta Mazzeo Domenica Lorusso Giovanni Scambia Stefania Canova Teresa Di Palma Giulia Tasca Mara Mantiero Emanuele Naglieri Claudia Andreetta Martina Rauso Anna Elisabetta Brunetti Letizia Laera Chiara Abe Source Type: research
Dedicated financial hardship screening adds value to routine distress screening among gynecologic cancer patients
CONCLUSIONS: Dedicated FH screening was feasible and acceptable, but sensitivity was low. Importantly, 40% of women with FH would not have been identified with distress screening alone.PMID:38518528 | DOI:10.1016/j.ygyno.2024.03.014 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - March 22, 2024 Category: Cancer & Oncology Authors: Margaret I Liang Jhalak D Dholakia Grace M Lee Lingling Wang Tavonna D Kako Isabella Blair Courtney P Williams Rebecca C Arend Warner K Huh Gabrielle B Rocque Maria Pisu Source Type: research
Response to the letter to the editor
Gynecol Oncol. 2024 Mar 20:S0090-8258(24)00158-6. doi: 10.1016/j.ygyno.2024.03.013. Online ahead of print.NO ABSTRACTPMID:38514301 | DOI:10.1016/j.ygyno.2024.03.013 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - March 21, 2024 Category: Cancer & Oncology Authors: Dongjo Ban Stephen N Housley Lilya V Matyunina L DeEtte McDonald Victoria L Bae-Jump Benedict B Benigno Jeffrey Skolnick John F McDonald Source Type: research
